Peptide handling by HLA-B27 subtypes influences their biological behavior, association with ankylosing spondylitis and susceptibility to endoplasmic reticulum aminopeptidase 1 (ERAP1)

Molecular and Cellular Proteomics

Volumn 13, Issue 12, 2014, Pages 3367-3380

  García Medel, Noel ^a   Sanz Bravo, Alejandro ^a   Alvarez Navarro, Carlos ^a   Gómez Molina, Patricia ^a   Barnea, Eilon ^b   Marcilla, Miguel ^c   Admon, Arie ^b   López De Castro, José A ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1; EPITOPE; HLA B27 ANTIGEN; PEPTIDE; UNCLASSIFIED DRUG; ERAP1 PROTEIN, HUMAN; ISOPROTEIN; LIGAND; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANKYLOSING SPONDYLITIS; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENZYME SPECIFICITY; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; MOLECULAR STABILITY; PATHOGENICITY; PEPTIDOMICS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STABILITY; PROTEIN TRANSPORT; SEQUENCE ANALYSIS; THERMODYNAMICS; THERMOSTABILITY; CHEMISTRY; CYTOLOGY; GENE EXPRESSION; GENETICS; HEAT; LYMPHOCYTE; METABOLISM; PATHOLOGY; PROTEIN DEGRADATION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSFORMED CELL LINE;

AMINOPEPTIDASES; CELL LINE, TRANSFORMED; EPITOPES; GENE EXPRESSION; HLA-B27 ANTIGEN; HOT TEMPERATURE; HUMANS; LIGANDS; LYMPHOCYTES; PEPTIDES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN FOLDING; PROTEIN ISOFORMS; PROTEIN STABILITY; PROTEOLYSIS; RECOMBINANT PROTEINS; SPONDYLITIS, ANKYLOSING; THERMODYNAMICS;

EID: 84928261726     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M114.039214     Document Type: Article

References (70)

1. Benjamin, R., and Parham, P. (1990) Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol. Today 11, 137-142
2. Colbert, R. A., Tran, T. M., and Layh-Schmitt, G. (2014) HLA-B27 misfolding and ankylosing spondylitis. Mol. Immunol. 57, 44-51
3. Shaw, J., Hatano, H., and Kollnberger, S. (2014) The biochemistry and immunology of non-canonical forms of HLA-B27. Mol. Immunol. 57, 52-58
4. Bird, L. A., Peh, C. A., Kollnberger, S., Elliott, T., McMichael, A. J., and Bowness, P. (2003) Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling. Eur. J. Immunol. 33, 748-759
5. DeLay, M. L., Turner, M. J., Klenk, E. I., Smith, J. A., Sowders, D. P., and Colbert, R. A. (2009) HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis Rheum. 60, 2633-2643
6. Bowness, P., Ridley, A., Shaw, J., Chan, A. T., Wong-Baeza, I., Fleming, M., Cummings, F., McMichael, A., and Kollnberger, S. (2011) Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis. J. Immunol. 186, 2672-2680
7. Breban, M., Fernandez-Sueiro, J. L., Richardson, J. A., Hadavand, R. R., Maika, S. D., Hammer, R. E., and Taurog, J. D. (1996) T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats. J. Immunol. 156, 794-803
8. May, E., Dorris, M. L., Satumtira, N., Iqbal, I., Rehman, M. I., Lightfoot, E., and Taurog, J. D. (2003) CD8αβ T cells are not essential to the pathogenesis of arthritis or colitis in HLA-B27 transgenic rats. J. Immunol. 170, 1099-1105
9. Robinson, P. C., and Brown, M. A. (2014) Genetics of ankylosing spondylitis. Mol. Immunol. 57, 2-11
10. Sorrentino, R., Bockmann, R. A., and Fiorillo, M. T. (2014) HLA-B27 and antigen presentation: at the crossroads between immune defense and autoimmunity. Mol. Immunol. 57, 22-27
11. Marcilla, M., and Lopez de Castro, J. A. (2008). Peptides: the cornerstone of HLA-B27 biology and pathogenetic role in spondyloarthritis. Tissue Antigens 71, 495-506
12. Serwold, T., Gonzalez, F., Kim, J., Jacob, R., and Shastri, N. (2002) ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 419, 480-483
13. Saric, T., Chang, S. C., Hattori, A., York, I. A., Markant, S., Rock, K. L., Tsujimoto, M., and Goldberg, A. L. (2002) An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat. Immunol. 3, 1169-1176
14. The TASK and WTCCC2 Consortia (2011). Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat. Genet. 43, 761-767
15. Garcia-Medel, N., Sanz-Bravo, A., Van Nguyen, D., Galocha, B., Gomez-Molina, P., Martin-Esteban, A., Alvarez-Navarro, C., and López de Castro, J. A. (2012). Functional interaction of the ankylosing spondylitisassociated endoplasmic reticulum aminopeptidase 1 polymorphism and HLA-B27 in vivo. Mol. Cell. Proteomics 11, 1416-1429
16. Lopez-Larrea, C., Sujirachato, K., Mehra, N. K., Chiewsilp, P., Isarangkura, D., Kanga, U., Dominguez, O., Coto, E., Peña, M., Setien, F., and Gonzalez-Roces, S. (1995) HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Evidence for new associations. Tissue Antigens 45, 169-176
17. D'Amato, M., Fiorillo, M. T., Carcassi, C., Mathieu, A., Zuccarelli, A., Bitti, P. P., Tosi, R., and Sorrentino, R. (1995) Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur. J. Immunol. 25, 3199-3201
18. Varnavidou-Nicolaidou, A., Karpasitou, K., Georgiou, D., Stylianou, G., Kokkofitou, A., Michalis, C., Constantina, C., Gregoriadou, C., and Kyriakides, G. (2004) HLA-B27 in the Greek Cypriot population: distribution of subtypes in patients with ankylosing spondylitis and other HLA-B27-related diseases. The possible protective role of B∗2707. Hum. Immunol. 65, 1451-1454
19. Diaz-Pena, R., Lopez-Vazquez, A., and Lopez-Larrea, C. (2012) Old and new HLA associations with ankylosing spondylitis. Tissue Antigens 80, 205-213
20. Rojo, S., Aparicio, P., Hansen, J. A., Choo, S. Y., and Lopez de Castro, J. A. (1987). Structural analysis of an HLA-B27 functional variant, B27d, detected in American blacks. J. Immunol. 139, 3396-3401
21. Choo, S. Y., St. John, T., Orr, H. T., and Hansen, J. A. (1988) Molecular analysis of the variant alloantigen HLA-B27d (HLA- B∗2703) identifies a unique single amino acid substitution. Hum. Immunol. 21, 209-219
22. Colbert, R. A., Rowland Jones, S. L., McMichael, A. J., and Frelinger, J. A. (1994) Differences in peptide presentation between B27 subtypes: the importance of the P1 side chain in maintaining high affinity peptide binding to B∗2703. Immunity 1, 121-130
23. Boisgérault, F., Tieng, V., Stolzenberg, M. C., Dulphy, N., Khalil, I., Tamouza, R., Charron, D., and Toubert, A. (1996) Differences in endogenous peptides presented by HLA-B∗2705 and B∗2703 allelic variants: implications for susceptibility to spondylarthropathies. J. Clin. Invest. 98, 2764-2770
24. Villadangos, J. A., Galocha, B., Lopez, D., Calvo, V., and Lopez de Castro, J. A. (1992). Role of binding pockets for amino-terminal peptide residues in HLA-B27 allorecognition. J. Immunol. 149, 505-510
25. Brown, M., Jepson, A., Young, A., Whittle, H., Greenwood, B., and Wordsworth, P. (1997) Spondyloarthritis in West Africa: evidence for a non-B27 protective effect. Ann. Rheum. Dis. 56, 68-70
26. Zemmour, J., Little, A. M., Schendel, D. J., and Parham P. (1992) The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J. Immunol. 148, 1941-1948
27. Calvo, V., Rojo, S., Lopez, D., Galocha, B., and Lopez de Castro, J. A. (1990). Structure and diversity of HLA-B27-specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism. J. Immunol. 144, 4038-4045
28. Villadangos, J. A., Galocha, B., and Lopez de Castro, J. A. (1994). Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity. J. Immunol. 152, 2317-2323
29. Ramos, M., Paradela, A., Vazquez, M., Marina, A., Vazquez, J., and Lopez de Castro, J. A. (2002). Differential association of HLA-B∗2705 and B∗2709 to ankylosing spondylitis correlates with limited peptide subsets but not with altered cell surface stability. J. Biol. Chem. 277, 28749-28756
30. Gomez, P., Montserrat, V., Marcilla, M., Paradela, A., and López de Castro, J. A. (2006). B∗2707 differs in peptide specificity from B∗2705 and B∗2704 as much as from HLA-B27 subtypes not associated to spondyloarthritis. Eur. J. Immunol. 36, 1867-1881
31. Barnstable, C. J., Bodmer, W. F., Brown, G., Galfre, G., Milstein, C., Williams, A. F., and Ziegler, A. (1978) Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens. New tools for genetic analysis. Cell 14, 9-20
32. Paradela, A., Garcia-Peydro, M., Vazquez, J., Rognan, D., and Lopez de Castro, J. A. (1998). The same natural ligand is involved in allorecognition of multiple HLA-B27 subtypes by a single T cell clone: role of peptide and the MHC molecule in alloreactivity. J. Immunol. 161, 5481-5490
33. Paradela, A., Alvarez, I., Garcia-Peydro, M., Sesma, L., Ramos, M., Vazquez, J., and Lopez de Castro, J. A. 2000. Limited diversity of peptides related to an alloreactive T cell epitope in the HLA-B27-bound peptide repertoire results from restrictions at multiple steps along the processing-loading pathway. J. Immunol. 164, 329-337
34. Garcia-Medel, N., Sanz-Bravo, A., Barnea, E., Admon, A., and Lopez de Castro, J. A. (2012). The origin of proteasome-inhibitor resistant HLA class I peptidomes: a study with HLA-A∗68:01. Mol. Cell. Proteomics 11, 1-15
35. Marcilla, M., Alpizar, A., Lombardia, M., Ramos-Fernandez, A., Ramos, M., and Albar, J. P. (2014) Increased diversity of the HLA-B40 ligandome by the presentation of peptides phosphorylated at their main anchor residue. Mol. Cell. Proteomics 13, 462-474
36. Beer, I., Barnea, E., Ziv, T., and Admon, A. (2004) Improving large-scale proteomics by clustering of mass spectrometry data. Proteomics 4, 950-960
37. Eng, J. K., McCormack, A. L., and Yates, J. R. (1994) An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Amer. Soc. Mass. Spect. 5, 976-989
38. Perkins, D. N., Pappin, D. J., Creasy, D. M., and Cottrell, J. S. (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20, 3551-3567
39. Cox, J., and Mann, M. (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-1372
40. Elias, J. E., and Gygi, S. P. (2007) Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4, 207-214
41. Elias, J. E., and Gygi, S. P. (2010) Target-decoy search strategy for mass spectrometry-based proteomics. Methods Mol. Biol. 604, 55-71
42. Medina-Aunon, J. A., Paradela, A., Macht, M., Thiele, H., Corthals, G., and Albar, J. P. (2010) Protein information and knowledge extractor: discovering biological information from proteomics data. Proteomics 10, 3262-3271
43. Diez-Rivero, C. M., Chenlo, B., Zuluaga, P., and Reche, P. A. (2010) Quantitative modeling of peptide binding to TAP using support vector machine. Proteins 78, 63-72
44. Hearn, A., York, I. A., and Rock, K. L. (2009) The specificity of trimming of MHC class I-presented peptides in the endoplasmic reticulum. J. Immunol. 183, 5526-5536
45. Hassan, C., Kester, M. G., de Ru, A. H., Hombrink, P., Drijfhout, J. W., Nijveen, H., Leunissen, J. A., Heemskerk, M. H., Falkenburg, J. H., and van Veelen, P. A. (2013) The human leukocyte antigen-presented ligandome of B lymphocytes. Mol. Cell Proteomics 12, 1829-1843
46. Alvarez, I., Martí, M., Vazquez, J., Camafeita, E., Ogueta, S., and Lopez de Castro, J. A. (2001). The Cys-67 residue of HLA-B27 influences cell surface stability, peptide specificity, and T-cell antigen presentation. J. Biol. Chem. 276, 48740-48747
47. Ben Dror, L., Barnea, E., Beer, I., Mann, M., and Admon, A. (2010) The HLA-B∗2705 peptidome. Arthritis Rheum. 62, 420-429
48. Infantes, S., Lorente, E., Barnea, E., Beer, I., Barriga, A., Lasala, F., Jimenez, M., Admon, A., and Lopez, D. (2013) Natural HLA-B∗2705 protein ligands with glutamine as anchor motif: implications for HLA-B27 association with spondyloarthropathy. J. Biol. Chem. 288, 10882-10889
49. Sesma, L., Montserrat, V., Lamas, J. R., Marina, A., Vazquez, J., and Lopez de Castro, J. A. (2002). The peptide repertoires of HLA-B27 subtypes differentially associated to spondyloarthropathy (B∗2704 and B∗2706) differ by specific changes at three anchor positions. J. Biol. Chem. 277, 16744-16749
50. Marti, M., Alvarez, I., Montserrat, V., and Lopez de Castro, J. A. (2001). Large sharing of T-cell epitopes and natural ligands between HLA-B27 subtypes (B∗2702 and B∗2705) associated with spondyloarthritis. Tissue Antigens 58, 351-362
51. Van Endert, P. M., Riganelli, D., Greco, G., Fleischhauer, K., Sidney, J., Sette, A., and Bach, J. F. (1995) The peptide-binding motif for the human transporter associated with antigen processing. J. Exp. Med. 182, 1883-1895
52. WTCC Consortium (2007) Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat. Genet. 39, 1329-1337
53. Haroon, N., Tsui, F. W., Uchanska-Ziegler, B., Ziegler, A., and Inman, R. D. (2012) Endoplasmic reticulum aminopeptidase 1 (ERAP1) exhibits functionally significant interaction with HLA-B27 and relates to subtype specificity in ankylosing spondylitis. Ann. Rheum. Dis. 71, 589-595
54. Villadangos, J. A., Galocha, B., Garcia, F., Albar, J. P., and Lopez de Castro, J. A. (1995). Modulation of peptide binding by HLA-B27 polymorphism in pockets A and B, and peptide specificity of B∗2703. Eur. J. Immunol. 25, 2370-2377
55. Montserrat, V., Galocha, B., Marcilla, M., Vazquez, M., and Lopez de Castro, J. A. (2006). HLA-B∗2704, an allotype associated with ankylosing spondylitis, is critically dependent on transporter associated with antigen processing and relatively independent of tapasin and immunoproteasome for maturation, surface expression, and T cell recognition: relationship to B∗2705 and B∗2706. J. Immunol. 177, 7015-7023
56. Williams, A. P., Peh, C. A., Purcell, A. W., McCluskey, J., and Elliott, T. S. (2002) Optimization of the MHC class I peptide cargo is dependent on tapasin. Immunity. 16, 509-520
57. Galocha, B., and López de Castro, J. A. (2008). Folding of HLA-B27 subtypes is determined by the global effect of polymorphic residues and shows incomplete correspondence to ankylosing spondylitis. Arthritis Rheum. 58, 401-412
58. Galocha, B., and López de Castro, J. A. (2010). Mutational analysis reveals a complex interplay of peptide binding and multiple biological features of HLA-B27. J. Biol. Chem. 285, 39180-39190
59. Lopez-Larrea, C., Mijiyawa, M., Gonzalez, S., Fernandez-Morera, J. L., Blanco-Gelaz, M. A., Martinez-Borra, J., and Lopez-Vazquez, A. (2002) Ankylosing spondylitis is associated with HLA-B∗1403 in a West African population. Arthritis Rheum. 46, 2968-2971
60. Diaz-Pena, R., Blanco-Gelaz, M. A., Njobvu, P., Lopez-Vazquez, A., Suarez-Alvarez, B., and Lopez-Larrea, C. (2008) Influence of HLA-B∗5703 and HLA-B∗1403 on susceptibility to spondyloarthropathies in the Zambian population. J. Rheumatol. 35, 2236-2240
61. Merino, E., Galocha, B., Vazquez, M. N., and Lopez de Castro, J. A. (2008). Disparate folding and stability of the ankylosing spondylitis-associated HLA-B∗1403 and B∗2705 proteins. Arthritis Rheum. 58, 3693-3704
62. Merino, E., Montserrat, V., Paradela, A., and Lopez de Castro, J. A. (2005). Two HLA-B14 subtypes (B∗1402 and B∗1403) differentially associated with ankylosing spondylitis differ substantially in peptide specificity, but have limited peptide and T-cell epitope sharing with HLA-B27. J. Biol. Chem. 280, 35868-35880
63. Daniel, S., Brusic, V., Caillat-Zucman, S., Petrovsky, N., Harrison, L., Riganelli, D., Sinigaglia, F., Gallazzi, F., Hammer, J., and Van Endert, P. M. (1998) Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules. J. Immunol. 161, 617-624
64. Herberts, C. A., Neijssen, J. J., de Haan, J., Janssen, L., Drijfhout, J. W., Reits, E. A., and Neefjes, J. J. (2006) Cutting edge: HLA-B27 acquires many N-terminal dibasic peptides: coupling cytosolic peptide stability to antigen presentation. J. Immunol. 176, 2697-2701
65. Cortes, A., Hadler, J., Pointon, J. P., Robinson, P. C., Karaderi, T., Leo, P., Cremin, K., Pryce, K., Harris, J., Lee, S., Joo, K. B., Shim, S. C., Weisman, M., Ward, M., Zhou, X., Garchon, H. J., Chiocchia, G., Nossent, J., Lie, B. A., Forre, O., Tuomilehto, J., Laiho, K., Jiang, L., Liu, Y., Wu, X., Bradbury, L. A., Elewaut, D., Burgos-Vargas, R., Stebbings, S., Appleton, L., Farrah, C., Lau, J., Kenna, T. J., Haroon, N., Ferreira, M. A., Yang, J., Mulero, J., Fernandez-Sueiro, J. L., Gonzalez-Gay, M. A., Lopez-Larrea, C., Deloukas, P., Donnelly, P., Bowness, P., Gafney, K., Gaston, H., Gladman, D. D., Rahman, P., Maksymowych, W. P., Xu, H., Crusius, J. B., van der Horst-Bruinsma, I. E., Chou, C. T., Valle-Onate, R., Romero-Sanchez, C., Hansen, I. M., Pimentel-Santos, F.M., Inman, R. D., Videm, V., Martin, J., Breban, M., Reveille, J. D., Evans, D. M., Kim, T. H., Wordsworth, B. P., and Brown, M. A. (2013) Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat. Genet. 45, 730-738
66. Chen, L., Fischer, R., Peng, Y., Reeves, E., McHugh, K., Ternette, N., Hanke, T., Dong, T., Elliott, T., Shastri, N., Kollnberger, S., James, E., Kessler, B., and Bowness, P. (2014) Critical role of endoplasmic reticulum aminopeptidase 1 in determining the length and sequence of peptides bound and presented by HLA-B27. Arthritis Rheumatol. 66, 284-294
67. Mear, J. P., Schreiber, K. L., Münz, C., Zhu, X., Stevanovic, S., Rammensee, H. G., Rowland-Jones, S. L., and Colbert, R. A. (1999) Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. J. Immunol. 163, 6665-6670
68. Dangoria, N. S., DeLay, M. L., Kingsbury, D. J., Mear, J. P., Uchanska-Ziegler, B., Ziegler, A., and Colbert, R. A. (2002) HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum. J. Biol. Chem. 277, 23459-23468
69. Bowness, P. (2002) HLA B27 in health and disease: a double-edged sword? Rheumatology 41, 857-868
70. Cauli, A., Shaw, J., Giles, J., Hatano, J., Rysnik, O., Payeli, S., McHugh, K., Dessole, G., Porru, G., Desogus, E., Fiedler, S., Holper, S., Carette, A., Blanco-Gelaz, M. A., Vacca, A., Piga, M., Ibba, V., Garau, P., La Nasa, G., Lopez-Larrea, C., Mathieu, A., Renner, C., Bowness, P., and Kollnberger, S. (2013) The arthritis-associated HLA-B∗27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLAB∗27:09. Rheumatology 52, 1952-1962